Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001104659-22-011517

Chief Scientific Officer gave up 2,183 shares (to pay taxes)

  • Chief Scientific Officer acquired 2,106 shares (grant or award)
  • Chief Scientific Officer acquired 6,166 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Roberts M Scot · Chief Scientific Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-01-31 Grant or award : show line 1 in the form +2,106 $6.86 $14,447 13,717 D
2022-02-01 Exercise or conversion : show line 2 in the form +6,166 19,883 D
2022-02-01 Shares withheld for taxes : show line 3 in the form −2,183 $7.98 $17,420 17,700 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2022-02-01 Exercise or conversion : show line 4 in the form Restricted Stock Units −6,166 18,498 D
2022-02-02 Grant or award : show line 5 in the form Stock Options (option to buy) +91,600 91,600 D
2022-02-02 Grant or award : show line 6 in the form Restricted Stock Units +31,100 31,100 D
Loading xslF345X03/tm225504-1_4seq1.xml…